Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Vectors and genetically engineered immune cells expressing metabolic pathway modulators and uses in adoptive cell therapy

Vectors and genetically engineered immune cells expressing metabolic pathway modulators and uses in adoptive cell therapy

US Patent 11020429 · Granted Jun 1, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Artificial cell death polypeptide for chimeric antigen receptor and uses thereof2025
Modified chimeric receptors and related compositions and methods2024
Compositions and methods for immune cell modulation in adoptive immunotherapies2024
Epigenetic analysis of cell therapy and related methods2023